Teodora Djikić

444 total citations
14 papers, 299 citations indexed

About

Teodora Djikić is a scholar working on Organic Chemistry, Computational Theory and Mathematics and Molecular Biology. According to data from OpenAlex, Teodora Djikić has authored 14 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 7 papers in Computational Theory and Mathematics and 6 papers in Molecular Biology. Recurrent topics in Teodora Djikić's work include Computational Drug Discovery Methods (7 papers), Synthesis and biological activity (5 papers) and Receptor Mechanisms and Signaling (3 papers). Teodora Djikić is often cited by papers focused on Computational Drug Discovery Methods (7 papers), Synthesis and biological activity (5 papers) and Receptor Mechanisms and Signaling (3 papers). Teodora Djikić collaborates with scholars based in Serbia, Türkiye and Italy. Teodora Djikić's co-authors include Katarina Nikolić, Dušan Ružić, Kemal Yelekçi, Nemanja Djoković, Ş. Güniz Küçükgüzel, Lazaros Mavridis, Danica Agbaba, John B. O. Mitchell, Fikrettin Şahιn and Özge Çevik and has published in prestigious journals such as Molecules, Frontiers in Neuroscience and European Journal of Pharmaceutical Sciences.

In The Last Decade

Teodora Djikić

12 papers receiving 291 citations

Peers

Countries citing papers authored by Teodora Djikić

Since Specialization

Citations

This map shows the geographic impact of Teodora Djikić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teodora Djikić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teodora Djikić more than expected).

Fields of papers citing papers by Teodora Djikić

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teodora Djikić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teodora Djikić. The network helps show where Teodora Djikić may publish in the future.

Co-authorship network of co-authors of Teodora Djikić

This figure shows the co-authorship network connecting the top 25 collaborators of Teodora Djikić. A scholar is included among the top collaborators of Teodora Djikić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teodora Djikić. Teodora Djikić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Scaffold‐Based Libraries Versus Make‐on‐Demand Space: A Comparative Assessment of Chemical Content 2025 ·ChemMedChem ·Linh T. Bui, Teodora Djikić, Guillaume Bret, Frédéric Bihel, Esther Kellenberger	0
2	Integration of 3D-QSAR, molecular docking, and machine learning techniques for rational design of nicotinamide-based SIRT2 inhibitors 2024 ·Computational Biology and Chemistry ·(unknown), Nemanja Djoković, Teodora Djikić, Katarina Nikolić	0
3	Synthesis and Biological Activity of a Cytostatic Inhibitor of MLLr Leukemia Targeting the DOT1L Protein 2021 ·Molecules ·Corentin Bon, Yang Si, (unknown), (unknown), (unknown), (unknown), Corinne Jallet, Dušan Ružić, Nemanja Djoković, Teodora Djikić, Katarina Nikolić, Ludovic Halby, Paola B. Arimondo	11
4	Application of in vitro PAMPA technique and in silico computational methods for blood-brain barrier permeability prediction of novel CNS drug candidates 2021 ·European Journal of Pharmaceutical Sciences ·(unknown), Teodora Djikić, (unknown), Katarina Nikolić	37
5	An Integrative in silico Drug Repurposing Approach for Identification of Potential Inhibitors of SARS‐CoV‐2 Main Protease 2021 ·Molecular Informatics ·Nemanja Djoković, Dušan Ružić, Teodora Djikić, Sandra Cvijić, (unknown), Svetlana Ibrić, Katarina Baralić, Aleksandra Buha Djordjević, Marijana Ćurčić, Danijela Đukić-Ćosić, Katarina Nikolić	7
6	Deciphering Imidazoline Off‐targets by Fishing in the Class A of GPCR field 2020 ·Molecular Informatics ·Teodora Djikić, (unknown), (unknown), Marco Radi, Nevena Veljković, Henri Xhaard, Katarina Nikolić	1
7	In silico identification of novel 5-HT_2A antagonists supported with ligand- and target-based drug design methodologies 2020 ·Journal of Biomolecular Structure and Dynamics ·(unknown), Dušan Ružić, (unknown), Teodora Djikić, Katarina Nikolić	10
8	In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs 2020 ·Frontiers in Chemistry ·(unknown), Dušan Ružić, Nemanja Djoković, Teodora Djikić, Katarina Nikolić	94
9	Synthesis, anticancer activity, and molecular modeling of etodolac‐thioether derivatives as potent methionine aminopeptidase (type II) inhibitors 2018 ·Archiv der Pharmazie ·(unknown), Özge Çevik, Kemal Yelekçi, Teodora Djikić, Ş. Güniz Küçükgüzel	22
10	Synthesis, Molecular Modelling and Antibacterial Activity Against Helicobacter pylori of Novel Diflunisal Derivatives as Urease Enzyme Inhibitors 2018 ·Letters in Drug Design & Discovery ·(unknown), Teodora Djikić, (unknown), Kemal Yelekçi, Fikrettin Şahιn, Ş. Güniz Küçükgüzel	8
11	Synthesis, Molecular Docking and Anticancer Activity of Diflunisal Derivatives as Cyclooxygenase Enzyme Inhibitors 2018 ·Molecules ·(unknown), Teodora Djikić, (unknown), Nezaket Türkel, Kemal Yelekçi, Fikrettin Şahιn, Ş. Güniz Küçükgüzel	24
12	Human dopamine transporter: the first implementation of a combined in silico/in vitro approach revealing the substrate and inhibitor specificities 2018 ·Journal of Biomolecular Structure and Dynamics ·Teodora Djikić, (unknown), Francesca Spyrakis, Thorsten Lau, Paolo Benedetti, Gavin P. Davey, Patrick D. Schloss, Kemal Yelekçi	7
13	Drug Design for CNS Diseases: Polypharmacological Profiling of Compounds Using Cheminformatic, 3D-QSAR and Virtual Screening Methodologies 2016 ·Frontiers in Neuroscience ·Katarina Nikolić, Lazaros Mavridis, Teodora Djikić, (unknown), Danica Agbaba, Kemal Yelekçi, John B. O. Mitchell	56
14	Synthesis and Screening of Human Monoamine Oxidase‐A Inhibitor Effect of New 2‐Pyrazoline and Hydrazone Derivatives 2015 ·Archiv der Pharmazie ·(unknown), İpek Baysal, Samiye Yabanoğlu‐Çiftçi, Teodora Djikić, Kemal Yelekçi, Gülberk Uçar, Rahmiye Ertan	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact